Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRAX-944 Phase 2 in Essential Tremor
NCT05021978Phase 2Completed
- Sponsor
- Praxis Precision Medicines
- Start
- Mar 2020
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of ulixacaltamide in essential tremor (ET), sponsored by Praxis Precision Medicines. Started Mar 2020; status: completed.
02
Drugs
ulixacaltamide
03
Conditions
essential tremor (ET)
Beyond the preview
Go deeper on NCT05021978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05021978.